Betarmos, Ruel C.
HRN: 23-08-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/30/2023
06/06/2023
IV
1.5gram
Q6hrs
CAP-MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes